Review the timeline for Igalmi in at-home treatment of agitation in bipolar disorder and schizophrenia.
|Podcasts|September 27, 2019
How to Talk to Patients About Bipolar Disorder
Author(s)Chris Aiken, MD
The bipolar word can be frightening or confusing to patients, but there are ways to talk about it that engage them in recovery. More in this podcast.
Advertisement
How to talk about bipolar disorder, with Chris Aiken, MD
The bipolar word can be frightening or confusing to patients, but there are ways to talk about it that engage them in recovery. More in this podcast.
Advertisement
Related to this article
Mixed-feature depression can signal bipolar risk; spot red flags and consider lurasidone or lumateperone before standard antidepressants.
In the second positive phase 3 trial of lumateperone (Caplyta) for bipolar mania, participants saw improved manic symptoms vs placebo as early as day 3.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Major Depressive Disorder With Mixed Features: Diagnosis and Treatment
2
New National Guidance for Managing Medetomidine Intoxication and Withdrawal
3
FDA Shelves Fast-Track Drug Review Initiative
4
Ahead of the FDA Action Date: A Timeline of Igalmi for Agitation in Bipolar Disorder and Schizophrenia
5